Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,293,491
  • Shares Outstanding, K 30,890
  • Annual Sales, $ 12,730 K
  • Annual Income, $ -295,160 K
  • 60-Month Beta 2.16
  • Price/Sales 256.35
  • Price/Cash Flow N/A
  • Price/Book 4.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.66
  • Number of Estimates 9
  • High Estimate -0.36
  • Low Estimate -1.56
  • Prior Year -2.35
  • Growth Rate Est. (year over year) +71.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.71 +11.40%
on 11/26/19
111.00 -3.95%
on 11/14/19
-4.41 (-3.97%)
since 11/13/19
3-Month
95.71 +11.40%
on 11/26/19
142.27 -25.06%
on 09/16/19
-34.39 (-24.39%)
since 09/13/19
52-Week
90.14 +18.28%
on 12/27/18
196.00 -45.60%
on 05/07/19
-14.24 (-11.78%)
since 12/13/18

Most Recent Stories

More News
Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX(R) (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences, today...

GWPH : 106.62 (+0.87%)
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX(R) (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced...

GWPH : 106.62 (+0.87%)
Marijuana ETFs Bounce Back: Can the Rally Last?

Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.

TSLA : 358.39 (-0.36%)
AAPL : 275.15 (+1.36%)
GWPH : 106.62 (+0.87%)
IIPR : 74.01 (+0.49%)
CGC : 20.68 (-2.13%)
APHA : 5.50 (+4.36%)
TLRY : 18.60 (-1.74%)
ACB : 2.63 (+1.15%)
CRON : 7.28 (-0.27%)
THCX : 13.39 (+1.21%)
YOLO : 12.06 (unch)
TOKE : 15.52 (+0.88%)
CNBS : 13.63 (+0.16%)
P : 8.38 (-1.30%)
What's in the Cards for OrganiGram (OGI) in Q4 Earnings?

According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.

GWPH : 106.62 (+0.87%)
TLRY : 18.60 (-1.74%)
CRON : 7.28 (-0.27%)
OGI : 2.59 (+0.78%)
New Records and New Milestones

New Records and New Milestones

FTNT : 105.64 (+1.19%)
PAYC : 256.99 (+0.99%)
VXX : 15.53 (-4.14%)
GWPH : 106.62 (+0.87%)
ASND : 115.19 (-2.10%)
TRWH : 25.20 (+1.98%)
VAPO : 11.57 (-0.52%)
Haemonetics (HAE) Grows on New Products, Robust Plasma Sales

Haemonetics (HAE) witnesses a steady uptick in Plasma franchise, fueled by favorable price, volume and mix.

EW : 232.64 (+0.84%)
NUVA : 75.84 (+2.69%)
GWPH : 106.62 (+0.87%)
HAE : 116.49 (-0.58%)
GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day

GW Pharmaceuticals, NetGear, Cisco Systems and NetApp highlighted as Zacks Bull and Bear of the Day

CSCO : 45.30 (-0.81%)
NTGR : 23.78 (-3.94%)
NTAP : 63.24 (+0.81%)
GWPH : 106.62 (+0.87%)
Here's Why You Should Hold on to CVS Health (CVS) For Now

Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

NUVA : 75.84 (+2.69%)
HAE : 116.49 (-0.58%)
GWPH : 106.62 (+0.87%)
CVS : 73.59 (-0.90%)
CVS Health's New Plans With Aetna May Improve Health Outcomes

CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

NUVA : 75.84 (+2.69%)
HAE : 116.49 (-0.58%)
GWPH : 106.62 (+0.87%)
CVS : 73.59 (-0.90%)
Bull of the Day: GW Pharmaceuticals (GWPH)

Bull of the Day: GW Pharmaceuticals (GWPH)

GWPH : 106.62 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 110.38
1st Resistance Point 108.50
Last Price 106.62
1st Support Level 105.29
2nd Support Level 103.97

See More

52-Week High 196.00
Fibonacci 61.8% 155.56
Fibonacci 50% 143.07
Fibonacci 38.2% 130.58
Last Price 106.62
52-Week Low 90.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar